These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23190450)

  • 21. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model.
    Bakri SJ; Cameron JD; McCannel CA; Pulido JS; Marler RJ
    Am J Ophthalmol; 2006 Jul; 142(1):162-4. PubMed ID: 16815270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab (avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice.
    Heiduschka P; Julien S; Hofmeister S; Bartz-Schmidt KU; Schraermeyer U
    Retina; 2008 Jan; 28(1):46-55. PubMed ID: 18185137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro effects of bevacizumab treatment on newborn rat retinal cell proliferation, death, and differentiation.
    Miguel NC; Matsuda M; Portes AL; Allodi S; Mendez-Otero R; Puntar T; Sholl-Franco A; Krempel PG; Monteiro ML
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7904-11. PubMed ID: 23139275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Localisation of bevacizumab in the monkey retina after an intravitreal injection of Avastin].
    Schraermeyer U; Heiduschka P; Bartz-Schmidt KU
    Ophthalmologe; 2009 Jul; 106(7):619-24. PubMed ID: 18781309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration.
    Hosseini H; Lotfi M; Esfahani MH; Nassiri N; Khalili MR; Razeghinejad MR; Nouri-Mahdavi K
    Retina; 2012 May; 32(5):967-71. PubMed ID: 22146127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different Ipsi- and Contralateral Glial Responses to Anti-VEGF and Triamcinolone Intravitreal Injections in Rats.
    Di Pierdomenico J; García-Ayuso D; Jiménez-López M; Agudo-Barriuso M; Vidal-Sanz M; Villegas-Pérez MP
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3533-44. PubMed ID: 27379578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats.
    Ma J; Zhu T; Tang X; Ye P; Zhang Z
    Clin Exp Ophthalmol; 2010 Dec; 38(9):875-84. PubMed ID: 20653693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.
    Kubota T; Morita H; Tou N; Nitta N; Tawara A; Satoh H; Shimajiri S
    Retina; 2010 Mar; 30(3):468-72. PubMed ID: 19952991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Nishida K
    Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety evaluation of repeated intravitreal injections of bevacizumab and ranibizumab in rabbit eyes.
    Zayit-Soudry S; Zemel E; Loewenstein A; Perlman I
    Retina; 2010 Apr; 30(4):671-81. PubMed ID: 19952984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.
    Spitzer MS; Wallenfels-Thilo B; Sierra A; Yoeruek E; Peters S; Henke-Fahle S; Bartz-Schmidt KU; Szurman P;
    Br J Ophthalmol; 2006 Oct; 90(10):1316-21. PubMed ID: 16723358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of intravitreal injection of bevacizumab in rabbit eyes.
    Feiner L; Barr EE; Shui YB; Holekamp NM; Brantley MA
    Retina; 2006 Oct; 26(8):882-8. PubMed ID: 17031287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity assessment of intravitreal triamcinolone and bevacizumab in a retinal explant mouse model using two-photon microscopy.
    Schlichtenbrede FC; Mittmann W; Rensch F; Vom Hagen F; Jonas JB; Euler T
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5880-7. PubMed ID: 19578025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical localisation of intravitreally injected bevacizumab in the anterior chamber angle, iris and ciliary body of the primate eye.
    Peters S; Heiduschka P; Julien S; Bartz-Schmidt KU; Schraermeyer U
    Br J Ophthalmol; 2008 Apr; 92(4):541-4. PubMed ID: 18211933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
    Emerson MV; Lauer AK; Flaxel CJ; Wilson DJ; Francis PJ; Stout JT; Emerson GG; Schlesinger TK; Nolte SK; Klein ML
    Retina; 2007; 27(4):439-44. PubMed ID: 17420695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifocal electrophysiologic findings after intravitreal bevacizumab (avastin) treatment.
    Torres-Soriano ME; Cubas-Lorenzo V; García-Aguirre G; Hernández-Rojas M; Kon-Jara V; Díaz-Rubio J; Fromow-Guerra J; Quiroz-Mercado H; Jiménez-Sierra JM
    Retina; 2012 May; 32(5):972-6. PubMed ID: 22105506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis.
    Nakao S; Arima M; Ishikawa K; Kohno R; Kawahara S; Miyazaki M; Yoshida S; Enaida H; Hafezi-Moghadam A; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4323-8. PubMed ID: 22661475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.